2018
-
Fabrice Barlesi, MD
Posted: June 2018 The 2018 Heine H. Hansen Award recipient was IASLC Lung Cancer News Associate Editor Fabrice Barlesi, MD. The award was presented at the 2018 European Lung Cancer […]
-
Frances Shepherd, MD
Posted: June 2018 IASLC past-president Frances Shepherd, MD, has been awarded the 2018 Canada Gairdner Wightman Award for outstanding career leadership in medicine and medical science. Dr. Shepherd is a […]
-
Pasi A. Janne, MD, PhD
Posted: June 2018 Pasi A. Janne, MD, PhD, was awarded the Second AACR-Waun Ki Hong Award for Outstanding Achievement in Translational and Clinical Cancer Research. The award is given to […]
-
Primo N. Lara, Jr., MD
Posted: June 2018 Primo N. Lara, Jr., MD, has been named director of the National Cancer Institute–designated UC Davis Comprehensive Cancer Center, leading a team of more than 300 scientists […]
-
The Long Road Home
Figure. Prevalance of Water Pipe Usage Is Virtually at Epidemic Proportion in Parts of the Middle East Sources: Vardavas C, Filippidis F, Agaku I. http://tobaccocontrol.bmj.com. Accessed April 11, 2018. McKelvey […]
-
EGFR-Targeted Therapy: A New Beginning
Highlights from the IASLC 18th Lung Cancer Targeted Therapies Meeting keynote address. By Suresh S. Ramalingam, MD Posted: June 2018 EGFR-targeted therapy has entered a new phase as the result […]
-
Highlights of the 8th Edition of the TNM Staging System: Practicalities and Tools
Editor’s Note: The following was written on behalf of the IASLC Staging and Prognostic Factors Committee. The IASLC Staging and Prognostic Factors Committee (SPFC) proposed revisions to the lung cancer […]
-
The Lung Master Protocol: Results and Updates
By Vassiliki Papadimitrakopoulou, MD Posted: June 2018 The Lung Master Protocol Trial (Lung-MAP) was designed in 2014 as a phase II/III trial overseen by a private–public collaboration among institutions participating […]
-
Managing Medication Shortages of Life-Saving Oncologic Therapeutics
Natural disasters, such as Hurricane Maria, may have contributed to more acute shortages than previously experienced. By Jorge Garcia, PharmD, MS, MHA, MBA, and Dina B. Dumercy, PharmD, BCOP, BCPS […]
-
The Role for Trimodality Therapy in Stage III NSCLC
By Leah Lawrence Posted: June 2018 The use of trimodality therapy—the combination of chemoradiotherapy followed by surgery—remains controversial for patients with locally advanced cN2-N3 NSCLC. According to the National Comprehensive […]
View ILCN Archives
Provider Resources